Back to LCT Homepage Targeting Huntington's Disease, Stroke, Type 1 Diabetes and Haemophilia
Living Cell Technologies
LCT - Living Cell Technologies

News

News updates: Subscribe
Unsubscribe

Archive

June 5, 2008
LCT Expands Diabetes Clinical Trial
>more
June 3, 2008
LCT Lists on International OTCQX
>more
May 21, 2008
LCT interviewed by New Zealand TV program, Close Up
>video
May 12, 2008
LCT presents encapsulation technology at conference
>more
May 8, 2008
LCT features on Channel Ten News
>more
>video
May 8, 2008
LCT prepares to list on international OTCQX
>more
 

News

LCT granted approval to manufacture xeno products for human use
December 19, 2006

Living Cell Technologies Ltd (ASX:LCT) today announced it has received a licence from the New Zealand Government to manufacture a novel animal cell product for humans under Good Manufacturing
Practice (GMP).

The NZ regulator MedSafe issued a formal letter to LCT recommending a Licence to Manufacture Medicines be issued which will allow the use of its xenotransplant products in human patients. The facility will be used to manufacture cell therapy products including DiabeCell® - LCT's diabetes product.

The scope of the GMP accreditation includes the company's proprietary micro-encapsulation process and also the manufacture and preparation of free islets from neo-natal pigs.

Related Document
Download ( = 38Kb )

LCT - Living Cell Technologies

Q & A

What is xenotransplantation?
The use of living animal cells, tissues or organs in human therapeutics. >more

What is DiabeCell?
DiabeCell is a porcine pancreatic cell product for the treatment of insulin-dependent diabetes. >more

What is NeurotrophinCell?
A choroid plexus (brain) cell product with the potential to treat diseases of the nervous system such as Huntington's disease and stroke. >more

What is LCT's encapsulation technology?
The living cells are covered in a seaweed-derived coating (alginate encapsulation) to form capsules which eliminate the
need for toxic immunosuppressant drugs and allow the release of beneficial factors. >more
 
HomeContactSitemapLegalsPrivacy
  
graphic design and website design - PDF Communications Ltd